(Q30696956)

English

An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

An analytic framework for aligning observational and randomized trial data: Application to postmenopausal hormone therapy and coronary heart disease (English)

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

coronary artery disease

1 reference

based on heuristic

inferred from title

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2013

1 reference

Europe PubMed Central

PMC publication ID

19 August 2017

Statistics in biosciences

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24244222%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24244222%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24244222%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

The 2012 hormone therapy position statement of: The North American Menopause Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Treatments effects from randomized trials and propensity score analyses were similar in similar populations in an example from cardiac surgery.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Intervening on risk factors for coronary heart disease: an application of the parametric g-formula

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Use of disease risk scores in pharmacoepidemiologic studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Estrogen therapy and coronary-artery calcification.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

A simulation using data from a primary care practice database closely replicated the women's health initiative trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Comparison of dynamic treatment regimes via inverse probability weighting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Coronary heart disease in menopausal women: implications of primary and secondary prevention trials of hormones

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Postmenopausal hormone therapy: critical reappraisal and a unified hypothesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

WHI: Now that the dust has settled: a commentary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Estrogen plus progestin and the risk of coronary heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Understanding the divergent data on postmenopausal hormone therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Perspectives on the Women's Health Initiative trial of hormone replacement therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

The randomized world is not without its imperfections: reflections on the Women's Health Initiative Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Estrogen replacement therapy, atherosclerosis, and vascular function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Marginal structural models and causal inference in epidemiology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Randomized, controlled trials, observational studies, and the hierarchy of research designs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

A comparison of observational studies and randomized, controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Methods for analyzing health care utilization and costs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

On the treatment of grouped observations in life studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

20 June 2018

Hormones and heart disease in women: the timing hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Hormone replacement therapy, heart disease, and other considerations

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

The discrepancy between observational studies and randomized trials of menopausal hormone therapy: did expectations shape experience?

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Bridging the efficacy–effectiveness gap: a regulator's perspective on addressing variability of drug response

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Minimizing bias due to confounding by indication in comparative effectiveness research: the importance of restriction.

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Evaluating Medication Effects Outside of Clinical Trials: New-User Designs

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

The central role of the propensity score in observational studies for causal effects

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Commentary: hormones and heart disease: do trials and observational studies address different questions?

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Design of the Women’s Health Initiative Clinical Trial and Observational Study

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

Observational studies and clinical trials of menopausal hormone therapy: can they both be right?

1 reference

https://api.crossref.org/works/10.1007%2FS12561-012-9073-6

21 January 2018

The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

25 November 2018

Causal inference from longitudinal studies with baseline randomization.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3827690

25 November 2018

When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data

1 reference

https://pubmed.ncbi.nlm.nih.gov/24244222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HRT and the young at heart

1 reference

https://pubmed.ncbi.nlm.nih.gov/24244222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition

1 reference

https://pubmed.ncbi.nlm.nih.gov/24244222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When are observational studies as credible as randomised trials?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24244222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postmenopausal hormone therapy: a reversal of fortune

1 reference

https://pubmed.ncbi.nlm.nih.gov/24244222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of epoetin dose on hematocrit

1 reference

https://pubmed.ncbi.nlm.nih.gov/24244222

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12561-012-9073-6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24244222%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24244222%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24244222%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30696956&oldid=2194976391"